NTHRYS provides Sas Internships for interested candidates at its Hyderabad facility, Telangana.
Please refer below for more details including Fee strctures,
Eligibility, Protocols and Modules etc.,. Please do call / message / whatsapp for more details on 7993084748 [India - +91].
Eligibility: BSc / BTech / MSc / MTech / MPhil / PhD in relevant field studying or completed students.
Of course, here s a list of approaches in clinical research without mentioning SAS:
1.
Clinical Trials Data Management
This involves the systematic collection, storage, and organization of data from clinical trials to ensure its accuracy and reliability.
2.
Statistical Analysis
Statistical methods are applied to clinical trial data to assess the effectiveness and safety of treatments.
3.
CDISC Standards Implementation
The Clinical Data Interchange Standards Consortium (CDISC) provides standards for organizing and sharing clinical data in a consistent format.
4.
Adverse Event Analysis
This involves the examination of adverse events and their relationship to the study treatment.
5.
Patient Profiles and Listings
These are summaries of individual patient data, often used for reviewing patient characteristics and outcomes.
6.
Clinical Data Integration
Data integration combines information from various sources, such as electronic health records, to create a holistic view of patient data.
7.
Clinical Data Reporting
: Clinical reports, including comprehensive Clinical Study Reports (CSRs), are created to document trial results and comply with regulatory requirements.
8.
Survival Analysis
Survival analysis assesses the time until specific events occur, such as patient survival rates.
9.
Pharmacokinetic (PK) and Pharmacodynamic (PD) Analysis
These analyses examine drug concentration data and its effects on patients.
10.
Randomization and Blinding
Randomization ensures unbiased participant allocation, and blinding maintains study integrity.
11.
Data Visualization
Visual representations, such as graphs and charts, aid in data interpretation.
12.
Quality Control and Validation
Processes are in place to validate data and ensure its quality and regulatory compliance.
Various Report Formats that are involved in the analysis systems
1.
Clinical Study Reports (CSRs)
CSRs provide comprehensive documentation of a clinical trial, including its design, methodology, results, and conclusions. They serve as the primary source of information for regulatory submissions and decision-making.
2.
Safety Reports
Safety reports focus on the collection and analysis of safety-related data, including adverse events and serious adverse events (SAEs). The objective is to assess and report the safety profile of the study drug or treatment.
3.
Statistical Analysis Plan (SAP) Reports
SAP reports outline the statistical methods and procedures to be used for analyzing clinical trial data. They provide a clear plan for conducting statistical analyses to address research objectives.
4.
Patient Profiles
Patient profiles are summaries of individual patient data within a clinical trial. They aim to provide a detailed overview of patient demographics, baseline characteristics, and treatment outcomes.
5.
Data Listings
Data listings present tabular data summaries, often at the patient level, to allow for detailed review of individual patient data, including specific variables or endpoints of interest.
6.
Integrated Summaries
Integrated summaries consolidate data from multiple studies or trials, providing a holistic view of the safety and efficacy of a drug or treatment across different populations and settings.
7.
Data Quality and Validation Reports
These reports focus on assessing data quality, including validation checks and data cleaning summaries, to ensure data accuracy and compliance with regulatory standards.
8.
Pharmacokinetic (PK) and Pharmacodynamic (PD) Reports
PK reports analyze drug concentration data (PK) and its effects on patients (PD) to understand how the drug is absorbed, distributed, metabolized, and excreted and its impact on the body.
9.
Adverse Event Summary Reports
These reports summarize adverse event data, including the frequency, severity, and relationship to the study drug. The objective is to evaluate the safety of the drug or treatment.
10.
Randomization and Blinding Reports
Reports on the randomization process and the maintenance of blinding (masking) of study participants. The objective is to ensure unbiased participant allocation and study integrity.
11.
Data Visualization Reports
Data visualization reports use graphical representations such as charts and graphs to make complex clinical data more accessible, aiding in data interpretation and decision-making.
12.
Interim Analysis Reports
Interim analysis reports provide preliminary findings from a clinical trial, allowing for early assessments of the study s progress and potential modifications to the trial design.
13.
Regulatory Submission Documents
These documents include datasets, analysis files, and summaries required for regulatory submissions to demonstrate the safety and efficacy of the study drug or treatment to regulatory authorities.
14.
Laboratory Data Reports
Laboratory data reports summarize and analyze data collected from laboratory tests conducted during the clinical trial, providing insights into patient health and treatment effects.
15.
Dose Escalation Reports
In studies involving dose escalation, these reports track dose-response relationships and safety profiles to determine the optimal dose for further investigation.
16.
Compliance and Audit Trail Reports
Compliance reports demonstrate adherence to regulatory requirements, while audit trail reports provide a detailed record of data handling and processing activities for transparency and accountability.
Note: Approaches and Reports mentioned in this page are allocated based on selected internship title / duration. All the approaches or reports might not be allocated in a single internship title.
